New onset and exacerbation of psoriasis after COVID-19 vaccination
- PMID: 34869811
- PMCID: PMC8628636
- DOI: 10.1016/j.jdcr.2021.11.016
New onset and exacerbation of psoriasis after COVID-19 vaccination
Keywords: BCG, Bacillus Calmette-Guérin; CDC, Center for Disease Control; COVID 19; Th, T helper; VAERS, Vaccine Adverse Events Reporting System; general dermatology; medical dermatology; vaccine.
Conflict of interest statement
Dr Lebwohl is an employee of Mount Sinai Dermatology, which receives research funds from Regeneron-Sanofi, 10.13039/100006483Abbvie, 10.13039/100004336Novartis, 10.13039/100002429Amgen, Eli Lilly, 10.13039/100011110UCB Inc, 10.13039/100005205Janssen Research and Development, LLC, and Ortho Dermatologics. He has been the principal investigator for numerous clinical trials but has no personal financial gain. Authors Wei, Kresch, and Elbogen have no conflicts of interest to declare.
References
-
- COVID-19 vaccines. US Food and Drug Administration. https://www.fda.gov/emergency-preparedness-and-response/coronavirus-dise...
-
- COVID data tracker. Centers for Disease Control and Prevention. Data as of: August 15, 2021 6:00 am ET. https://covid.cdc.gov/covid-data-tracker/#vaccinations_vacc-total-admin-...
-
- Raaschou-Nielsen W. Psoriasis vaccinalis; report of two cases, one following BCG vaccination and one following vaccination against influenza. Acta Derm Venereol. 1955;35(1):37–42. - PubMed
Publication types
LinkOut - more resources
Full Text Sources